News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Helix BioMedix, Inc. (HXBM) Chief Scientific Officer Stepping Down, Company Focuses on Commercialization of Peptide Pipeline


2/16/2011 9:28:56 AM

BOTHELL, Wash.--(BUSINESS WIRE)--Helix BioMedix, Inc. (OTCBB:HXBM), a developer of bioactive peptides, today announced that Dr. Timothy Falla will leave his post as Vice President and Chief Scientific Officer effective February 28, 2011. Dr. Falla will assist the company on a consulting basis in managing the Helix BioMedix patent portfolio during a transitional period.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES